Cellular and Pharmacological Targets to Induce Coronary Arteriogenesis

By  

Current Cardiology Reviews, Vol. 10, Iss. 1, 2014-03 ,pp. : 29-37

Bentham Science Publishers

Access to resources Recommend Favorite

Altered Balance Between Extracellular Proteolysis and Antiproteolysis is Associated with Adaptive Coronary Arteriogenesis

By Cai W-j.   Vosschulte R.   Afsah-Hedjri A.   Koltai S.   Kocsis E.   Scholz D.   Kostin S.   Schaper W.   Schaper J.  

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 6, 2000-06 ,pp. : 997-1011

Academic Press

Access to resources Recommend Favorite

Connexin37, not Cx40 and Cx43, is Induced in Vascular Smooth Muscle Cells During Coronary Arteriogenesis

By Cai W-J.   Koltai S.   Kocsis E.   Scholz D.   Schaper W.   Schaper J.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 5, 2001-05 ,pp. : 957-967

Academic Press

Access to resources Recommend Favorite

Pharmacological Adjuvant Therapies in Primary Coronary Interventions: Bivalirudin

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 2, 2013-06 ,pp. : 106-114

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of No Reflow During Percutaneous Coronary Intervention

By  

Current Vascular Pharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 95-100

Bentham Science Publishers

Access to resources Recommend Favorite